rs2276541

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001106.4(ACVR2B):​c.53-5999G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.485 in 152,088 control chromosomes in the GnomAD database, including 19,989 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.49 ( 19989 hom., cov: 33)

Consequence

ACVR2B
NM_001106.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.365

Publications

9 publications found
Variant links:
Genes affected
ACVR2B (HGNC:174): (activin A receptor type 2B) Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. This gene encodes activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. [provided by RefSeq, Jul 2008]
ACVR2B Gene-Disease associations (from GenCC):
  • heterotaxy, visceral, 4, autosomal
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.607 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ACVR2BNM_001106.4 linkc.53-5999G>A intron_variant Intron 1 of 10 ENST00000352511.5 NP_001097.2 Q13705-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ACVR2BENST00000352511.5 linkc.53-5999G>A intron_variant Intron 1 of 10 1 NM_001106.4 ENSP00000340361.3 Q13705-1
ACVR2BENST00000465020.5 linkn.57-5999G>A intron_variant Intron 1 of 9 2

Frequencies

GnomAD3 genomes
AF:
0.485
AC:
73754
AN:
151970
Hom.:
19992
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.232
Gnomad AMI
AF:
0.485
Gnomad AMR
AF:
0.527
Gnomad ASJ
AF:
0.548
Gnomad EAS
AF:
0.463
Gnomad SAS
AF:
0.570
Gnomad FIN
AF:
0.549
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.612
Gnomad OTH
AF:
0.498
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.485
AC:
73780
AN:
152088
Hom.:
19989
Cov.:
33
AF XY:
0.484
AC XY:
36023
AN XY:
74352
show subpopulations
African (AFR)
AF:
0.232
AC:
9624
AN:
41482
American (AMR)
AF:
0.527
AC:
8058
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.548
AC:
1903
AN:
3472
East Asian (EAS)
AF:
0.462
AC:
2385
AN:
5166
South Asian (SAS)
AF:
0.570
AC:
2745
AN:
4814
European-Finnish (FIN)
AF:
0.549
AC:
5802
AN:
10568
Middle Eastern (MID)
AF:
0.497
AC:
146
AN:
294
European-Non Finnish (NFE)
AF:
0.612
AC:
41628
AN:
67980
Other (OTH)
AF:
0.496
AC:
1048
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1753
3506
5259
7012
8765
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.531
Hom.:
3030
Bravo
AF:
0.467
Asia WGS
AF:
0.516
AC:
1792
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.69
DANN
Benign
0.16
PhyloP100
0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276541; hg19: chr3-38512779; API